Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity ...

Those rehired by the Trump administration include at least 10 FDA staffers responsible for reviewing the safety of new food ...

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...

Robert F. Kennedy Jr. said the Trump administration would liberate Americans from the FDA’s “aggressive suppression” of vitamins, dietary supplements, and other substances.

The U.S. Food & Drug Administration (FDA) announced the recall of Frozen Supplemental Shakes due to potential Listeria contamination. According to the FDA, Lyons Magnus LLC ...

Eli Lilly has cut the price for vials of its weight-loss drug Zepbound sold online and expanded the range of doses in an ...

The supplement shakes were sold to hospitals and long-term care facilities, including nursing homes. There is a nationwide ...

The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...

Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in the U.S. at ...

The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...

The Outsourcing Facilities Association, a trade group representing compounders, filed a similar lawsuit in October last year ...

Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...